Clinical Intelligence
Systemic agents for psoriasis and their relevance to primary care
Simon Tso, William Hunt, Helen Frow and Andrew Ilchyshyn
British Journal of General Practice 2019; 69 (679): 96-97. DOI: https://doi.org/10.3399/bjgp19X701225
Simon Tso
Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry.
MD, MRCPRoles: Dermatology specialty registrar year 6
William Hunt
Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry.
BM BSRoles: Core medical trainee year 2
Helen Frow
Royal Devon and Exeter NHS Foundation Trust, Exeter.
MRCGPRoles: GP and associate specialist dermatology
Andrew Ilchyshyn
Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry.
FRCPRoles: Consultant dermatologist
In this issue
British Journal of General Practice
Vol. 69, Issue 679
February 2019
Systemic agents for psoriasis and their relevance to primary care
Simon Tso, William Hunt, Helen Frow, Andrew Ilchyshyn
British Journal of General Practice 2019; 69 (679): 96-97. DOI: 10.3399/bjgp19X701225
Jump to section
- Top
- Article
- INTRODUCTION
- WHAT ARE THE IMPORTANT SIDE EFFECTS OF SYSTEMIC AGENTS?
- CAN VACCINATIONS BE GIVEN WITH SYSTEMIC AGENTS?
- WHAT PRECONCEPTION AND BREASTFEEDING ADVICE SHOULD BE GIVEN TO PATIENTS ON SYSTEMIC AGENTS?
- CAN SYSTEMIC AGENTS BE STOPPED WHEN A PATIENT DEVELOPS AN INFECTION?
- DO SYSTEMIC AGENTS NEED TO BE STOPPED PRIOR TO ELECTIVE SURGERY?
- CONCLUSION
- Notes
- REFERENCES
- Figures & Data
- Info
- eLetters
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals